 |
|
Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma
Byung Soo Kwan, Jeong Han Kim, Seong Jun Park, Won Hyeok Choe, So Young Kwon, Byung-Chul Yoo
Korean J Intern Med. 2021;36(2):292-304. Published online 2020 Apr 3 DOI: https://doi.org/10.3904/kjim.2019.297
|
|
Citations to this article as recorded by
 Efficacy and Long-Term Outcomes of Direct-Acting Antivirals in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Jeong-Ju Yoo, Seul Ki Han, Soon Sun Kim, Hyun Yang, Eunju Kim, Seong Hee Kang, Young Eun Chon, Eileen L. Yoon, Hyun Phil Shin, Sangheun Lee, Do Young Kim, Gi Hyeon Seo, Hyung Joon Kim, Hyun Woong Lee
Gut and Liver.2026; 20(4): 665. CrossRef Evaluating long-term outcomes of direct-acting antiviral therapy in chronic hepatitis C: A retrospective study
Bo Ram Sung, Sang Goon Shim, Kwang Min Kim, Jung Won Lee, Jun Young Kim, Bo Kyeong Lee, Cheon Hoo Jun, Byung Soo Kwan
Medicine.2025; 104(50): e46449. CrossRef Direct-acting antivirals trigger a favorable, sustained virological response in patients with chronic hepatitis C infections and hepatocellular carcinoma
Won Sohn
The Korean Journal of Internal Medicine.2021; 36(2): 286. CrossRef
|